Genomic Valley Biotech Limited (BOM:539206)
India
· Delayed Price · Currency is INR 24.25
-1.27 (-4.98%)
At close: Apr 28, 2026
Genomic Valley Biotech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 0.45 | 0.06 | 0.41 | 0.03 | 0.11 | Upgrade
|
| Cash & Short-Term Investments | 0.07 | 0.45 | 0.06 | 0.41 | 0.03 | 0.11 | Upgrade
|
| Cash Growth | -98.31% | 644.62% | -85.30% | 1441.91% | -76.61% | -69.66% | Upgrade
|
| Accounts Receivable | - | 22.14 | 25.3 | 22.17 | - | 0.65 | Upgrade
|
| Other Receivables | - | - | 0.02 | 0.02 | 0.15 | 0.09 | Upgrade
|
| Receivables | - | 22.14 | 25.32 | 22.2 | 0.15 | 0.74 | Upgrade
|
| Inventory | - | 2.84 | - | - | - | - | Upgrade
|
| Other Current Assets | - | 0.78 | 3.72 | 3.16 | 11.19 | 0.79 | Upgrade
|
| Total Current Assets | - | 26.22 | 29.1 | 25.77 | 11.37 | 1.64 | Upgrade
|
| Property, Plant & Equipment | - | 0.09 | 0.02 | 0.03 | 17.47 | 63.34 | Upgrade
|
| Long-Term Investments | - | - | 0.17 | 4.35 | 4 | - | Upgrade
|
| Other Intangible Assets | - | - | - | - | 0.08 | 0.13 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | - | 0 | 0.08 | Upgrade
|
| Other Long-Term Assets | - | 9.05 | 14.05 | 14.05 | 5.05 | 11 | Upgrade
|
| Total Assets | - | 43.57 | 43.34 | 44.2 | 37.97 | 76.18 | Upgrade
|
| Accounts Payable | - | 0.1 | 6.02 | 6.11 | - | 0.4 | Upgrade
|
| Accrued Expenses | - | 0.31 | 0.03 | 1.74 | 0.25 | 0.18 | Upgrade
|
| Current Income Taxes Payable | - | 0.85 | - | - | - | - | Upgrade
|
| Other Current Liabilities | - | 3.33 | 1.87 | 1.09 | 1.9 | 8.13 | Upgrade
|
| Total Current Liabilities | - | 4.58 | 7.91 | 8.93 | 2.14 | 8.71 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 15.47 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 0.01 | 0 | 0 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 7.05 | 7.12 | Upgrade
|
| Total Liabilities | - | 4.58 | 7.92 | 8.94 | 9.19 | 31.3 | Upgrade
|
| Common Stock | - | 30.55 | 30.55 | 30.55 | 30.55 | 30.55 | Upgrade
|
| Retained Earnings | - | 5.97 | 2.41 | 2.26 | -4.22 | -4.13 | Upgrade
|
| Comprehensive Income & Other | - | 2.47 | 2.47 | 2.47 | 2.47 | 18.47 | Upgrade
|
| Shareholders' Equity | 39.26 | 38.98 | 35.42 | 35.27 | 28.79 | 44.88 | Upgrade
|
| Total Liabilities & Equity | - | 43.57 | 43.34 | 44.2 | 37.97 | 76.18 | Upgrade
|
| Total Debt | - | - | - | - | - | 15.47 | Upgrade
|
| Net Cash (Debt) | 0.07 | 0.45 | 0.06 | 0.41 | 0.03 | -15.36 | Upgrade
|
| Net Cash Growth | -98.31% | 644.62% | -85.30% | 1441.91% | - | - | Upgrade
|
| Net Cash Per Share | 0.02 | 0.15 | 0.02 | 0.14 | 0.01 | -5.03 | Upgrade
|
| Filing Date Shares Outstanding | 3.51 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | Upgrade
|
| Total Common Shares Outstanding | 3.51 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | Upgrade
|
| Working Capital | - | 21.64 | 21.19 | 16.84 | 9.23 | -7.08 | Upgrade
|
| Book Value Per Share | 12.64 | 12.76 | 11.60 | 11.55 | 9.42 | 14.69 | Upgrade
|
| Tangible Book Value | 39.26 | 38.98 | 35.42 | 35.27 | 28.71 | 44.75 | Upgrade
|
| Tangible Book Value Per Share | 12.64 | 12.76 | 11.60 | 11.55 | 9.40 | 14.65 | Upgrade
|
| Land | - | - | - | - | 20.55 | 54.66 | Upgrade
|
| Machinery | - | 0.13 | 0.03 | 2.97 | 3.27 | 9.07 | Upgrade
|
| Construction In Progress | - | - | - | - | - | 4.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.